Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy.
Chen S, Lin K, Li Q, Luo X, Xiao M, Chen M, Zhu H, Chen Y, Wu X, Zeng Y, Zhang Y, Ally IH, Xu J, Ren J, Chen Z, Hu J, Yang T. Chen S, et al. Among authors: luo x. J Cancer. 2021 Jul 25;12(18):5494-5505. doi: 10.7150/jca.50802. eCollection 2021. J Cancer. 2021. PMID: 34405012 Free PMC article.
Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
Zhang Y, Ye C, Zhu H, Zhuang Y, Chen S, Weng Y, Ren J, Luo X, Zheng J, Zheng X, Li J, Lan L, Xie Y, Han Z, Hu J, Yang T. Zhang Y, et al. Among authors: luo x. Front Immunol. 2023 Jan 24;13:1091188. doi: 10.3389/fimmu.2022.1091188. eCollection 2022. Front Immunol. 2023. PMID: 36761162 Free PMC article.
Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
Zhang Y, Zheng H, Ren J, Luo X, Zheng Z, Zheng J, Zheng X, Chen Y, Chen Z, Hu J, Yang T. Zhang Y, et al. Among authors: luo x. Hematol Oncol. 2021 Aug;39(3):380-389. doi: 10.1002/hon.2867. Epub 2021 Apr 13. Hematol Oncol. 2021. PMID: 33848027
Corrigendum to "Bone marrow mesenchymal stem cells alleviate the daunorubicin-induced subacute myocardial injury in rats through inhibiting infiltration of T lymphocytes and antigen-presenting cells" [Biomed. Pharmacother. 121 (2020) 109157].
Chen Q, Zhang Y, Zhu H, Yuan X, Luo X, Wu X, Chen S, Chen Y, Xu J, Issa HA, Zheng Z, Hu J, Yang T. Chen Q, et al. Among authors: luo x. Biomed Pharmacother. 2023 Aug;164:114940. doi: 10.1016/j.biopha.2023.114940. Epub 2023 May 29. Biomed Pharmacother. 2023. PMID: 37258310 Free article. No abstract available.
20,250 results
You have reached the last available page of results. Please see the User Guide for more information.